---
document_datetime: 2023-09-21 17:45:44
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cometriq-epar-all-authorised-presentations_en.pdf
document_name: cometriq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1189362
conversion_datetime: 2025-12-24 05:53:50.69003
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)   | Strength    | Pharmaceutical   | Route of       | Immediate Packaging        | Pack size                        |
|------------------|--------------|-------------|------------------|----------------|----------------------------|----------------------------------|
|                  | name         |             | Form             | Administration |                            |                                  |
| EU/1/13/890/001  | COMETRIQ     | 20 mg       | Capsule, hard    | Oral use       | Blister (PVC/PE/PCTFE/Alu) | 21 capsules                      |
| EU/1/13/890/002  | COMETRIQ     | 20 mg+80 mg | Capsule, hard    | Oral use       | Blister (PVC/PE/PCTFE/Alu) | 7 x 20 mg + 7 x 80 mg capsules   |
| EU/1/13/890/003  | COMETRIQ     | 20 mg+80 mg | Capsule, hard    | Oral use       | Blister (PVC/PE/PCTFE/Alu) | 21 x 20 mg + 7 x 80 mg capsules  |
| EU/1/13/890/004  | COMETRIQ     | 20 mg       | Capsule, hard    | Oral use       | Blister (PVC/PE/PCTFE/Alu) | 84 capsules                      |
| EU/1/13/890/005  | COMETRIQ     | 20 mg+80 mg | Capsule, hard    | Oral use       | Blister (PVC/PE/PCTFE/Alu) | 28 x 20 mg + 28 x 80 mg capsules |
| EU/1/13/890/006  | COMETRIQ     | 20 mg+80 mg | Capsule, hard    | Oral use       | Blister (PVC/PE/PCTFE/Alu) | 84 x 20 mg + 28 x 80 mg capsules |